Biohaven Ltd. (BHVN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NYSE
Market Cap: $2.09B
Last updated: Nov 17, 2026 at 11:04 AM ET
Biohaven Ltd. (BHVN) Earnings: Report Dates and Results
Biohaven (BHVN) is expected to report earnings on Mar 1, 2027. In the quarter ended Sep 30, 2026, Biohaven reported EPS of -$0.86, below the -$0.80 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
BHVN has an expected report date of Mar 1, 2027.
Earnings History
Of the 39 quarters below that had an estimate, BHVN beat 8 and missed 31. The widest gap in the table came in the quarter ended Jun 30, 2017, when EPS landed 191.80% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.86 | -$0.80 | N/A | -7.50% | Miss | N/A | 6 | 1 up, 2 down | Oct 29, 2026 | N/A |
| Jun 30, 2026 | -$0.91 | -$0.77 | -$0.77 - -$0.44 | -18.18% | Miss | N/A | 8 | 3 up, 3 down | Aug 10, 2026 | N/A |
| Mar 31, 2026 | -$0.69 | -$0.76 | -$1.07 - -$0.61 | +9.21% | Beat | N/A | 6 | 2 up, 2 down | May 4, 2026 | N/A |
| Dec 31, 2025 | -$0.90 | -$1.18 | -$1.21 - -$0.36 | +23.73% | Beat | N/A | 5 | 1 up, 0 down | Mar 2, 2026 | N/A |
| Sep 30, 2025 | -$1.47 | -$1.54 | -$1.80 - -$1.43 | +4.55% | Beat | N/A | 6 | 0 up, 3 down | Nov 10, 2025 | N/A |
| Jun 30, 2025 | -$1.63 | -$1.57 | -$2.32 - -$1.17 | -3.82% | Miss | N/A | 4 | 1 up, 1 down | Aug 11, 2025 | N/A |
| Mar 31, 2025 | -$1.64 | -$1.47 | -$1.70 - -$1.19 | -11.56% | Miss | N/A | 4 | 1 up, 0 down | May 12, 2025 | N/A |
| Dec 31, 2024 | -$1.71 | -$1.60 | -$1.75 - -$0.90 | -6.88% | Miss | N/A | 5 | 0 up, 0 down | Mar 3, 2025 | $3.84M |
| Sep 30, 2024 | -$1.74 | -$1.55 | -$2.19 - -$1.30 | -12.26% | Miss | N/A | 13 | 1 up, 0 down | Nov 12, 2024 | N/A |
| Jun 30, 2024 | -$3.50 | -$1.70 | -$2.44 - -$1.28 | -105.88% | Miss | N/A | 12 | 0 up, 0 down | Aug 8, 2024 | N/A |
| Mar 31, 2024 | -$1.77 | -$1.62 | -$1.97 - -$1.27 | -9.26% | Miss | N/A | 10 | 0 up, 0 down | May 9, 2024 | N/A |
| Dec 31, 2023 | -$1.81 | -$1.41 | -$1.62 - -$1.14 | -28.37% | Miss | N/A | 11 | 0 up, 0 down | Feb 29, 2024 | N/A |
| Sep 30, 2023 | -$1.50 | -$1.34 | -$1.40 - -$1.26 | -11.94% | Miss | N/A | 7 | 0 up, 0 down | Nov 14, 2023 | N/A |
| Jun 30, 2023 | -$1.32 | -$1.19 | -$1.34 - -$1.13 | -10.92% | Miss | N/A | 7 | 0 up, 1 down | Jul 31, 2023 | N/A |
| Mar 31, 2023 | -$1.03 | -$1.41 | -$1.63 - -$1.00 | +26.95% | Beat | N/A | 6 | 0 up, 0 down | May 12, 2023 | N/A |
| Dec 31, 2022 | -$3.32 | -$1.22 | -$1.56 - -$0.90 | -172.13% | Miss | N/A | 6 | 0 up, 0 down | Mar 23, 2023 | N/A |
| Sep 30, 2022 | -$1.75 | -$2.41 | N/A | +27.39% | Beat | N/A | 1 | 0 up, 0 down | Nov 9, 2022 | N/A |
| Jun 30, 2022 | -$6.21 | -$2.58 | N/A | -140.70% | Miss | N/A | N/A | N/A | Aug 5, 2022 | N/A |
| Mar 31, 2022 | -$2.97 | -$2.53 | N/A | -17.39% | Miss | N/A | N/A | N/A | May 10, 2022 | N/A |
| Dec 31, 2021 | -$3.01 | -$2.04 | N/A | -47.55% | Miss | N/A | N/A | N/A | Feb 25, 2022 | $190.01M |
| Sep 30, 2021 | -$2.63 | -$2.40 | N/A | -9.58% | Miss | N/A | N/A | N/A | Nov 9, 2021 | N/A |
| Jun 30, 2021 | -$3.23 | -$2.72 | N/A | -18.75% | Miss | N/A | N/A | N/A | Aug 9, 2021 | $92.93M |
| Mar 31, 2021 | -$4.21 | -$2.82 | N/A | -49.29% | Miss | N/A | N/A | N/A | May 10, 2021 | $43.82M |
| Dec 31, 2020 | -$3.62 | -$2.97 | N/A | -21.89% | Miss | N/A | N/A | N/A | Mar 1, 2021 | $35.11M |
| Sep 30, 2020 | -$3.27 | -$2.89 | N/A | -13.15% | Miss | N/A | N/A | N/A | Nov 9, 2020 | $17.66M |
| Jun 30, 2020 | -$3.08 | -$2.61 | N/A | -18.01% | Miss | N/A | N/A | N/A | Aug 10, 2020 | $9.70M |
| Mar 31, 2020 | -$3.07 | -$2.34 | N/A | -31.20% | Miss | N/A | N/A | N/A | May 7, 2020 | $1.15M |
| Dec 31, 2019 | -$2.85 | -$1.87 | N/A | -52.41% | Miss | N/A | N/A | N/A | Feb 25, 2020 | N/A |
| Sep 30, 2019 | -$2.04 | -$1.57 | N/A | -29.94% | Miss | N/A | N/A | N/A | Nov 1, 2019 | N/A |
| Jun 30, 2019 | -$4.67 | -$1.92 | N/A | -143.23% | Miss | N/A | N/A | N/A | Aug 8, 2019 | N/A |
| Mar 31, 2019 | -$1.41 | -$1.48 | N/A | +4.73% | Beat | N/A | N/A | N/A | May 7, 2019 | N/A |
| Dec 31, 2018 | -$1.34 | -$1.21 | N/A | -10.74% | Miss | N/A | N/A | N/A | Feb 28, 2019 | N/A |
| Sep 30, 2018 | -$1.53 | -$1.07 | N/A | -42.99% | Miss | N/A | N/A | N/A | Nov 14, 2018 | N/A |
| Jun 30, 2018 | -$1.01 | -$1.18 | N/A | +14.41% | Beat | N/A | N/A | N/A | Aug 14, 2018 | N/A |
| Mar 31, 2018 | -$2.32 | -$1.14 | N/A | -103.51% | Miss | N/A | N/A | N/A | May 15, 2018 | N/A |
| Dec 31, 2017 | -$0.75 | -$1.20 | N/A | +37.50% | Beat | N/A | N/A | N/A | Mar 6, 2018 | N/A |
| Sep 30, 2017 | -$1.19 | -$1.10 | N/A | -8.18% | Miss | N/A | N/A | N/A | Nov 14, 2017 | N/A |
| Jun 30, 2017 | -$1.78 | -$0.61 | N/A | -191.80% | Miss | N/A | N/A | N/A | Aug 14, 2017 | N/A |
| Mar 31, 2017 | -$1.74 | -$0.79 | N/A | -120.25% | Miss | N/A | N/A | N/A | May 5, 2017 | N/A |
| Dec 31, 2016 | Not reported | N/A | N/A | N/A | Not reported | N/A | N/A | N/A | Mar 1, 2017 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$5.64, after -$8.72 the year before. It was -$5.46 for the year ended Dec 31, 2017, the oldest of the 9 fiscal years below with reported EPS.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$5.64 | N/A |
| Dec 31, 2024 | -$8.72 | N/A |
| Dec 31, 2023 | -$5.66 | N/A |
| Dec 31, 2022 | -$14.25 | N/A |
| Dec 31, 2021 | -$13.08 | N/A |
| Dec 31, 2020 | -$13.04 | N/A |
| Dec 31, 2019 | -$10.97 | N/A |
| Dec 31, 2018 | -$6.20 | N/A |
| Dec 31, 2017 | -$5.46 | N/A |
| Dec 31, 2016 | Not reported | N/A |
Frequently Asked Questions About BHVN
When is Biohaven's next earnings date?
Biohaven's next earnings report is expected for Mar 1, 2027.
Did BHVN beat earnings estimates last quarter?
No. Biohaven reported EPS of -$0.86 for the quarter ended Sep 30, 2026, below the -$0.80 estimate by 7.50%.
What EPS do analysts expect from BHVN next quarter?
The consensus EPS estimate for Biohaven for the quarter ending Dec 31, 2026 is -$0.20 from 19 analysts, with estimates from -$0.83 to $2.07.
How often does BHVN beat earnings estimates?
Biohaven beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -1.31%.
BHVN pages: Overview, Earnings, Forecast, Financials, Competitors